Remicade Labeling Should Allow For Higher Dose Option, Arthritis Cmte. Says
Executive Summary
Centocor Remicade labeling should indicate that some patients may benefit from a higher dosage of the drug, but should also emphasize the greater safety risks associated with higher dosing, members of the FDA Arthritis Drugs Advisory Committee suggested.